
CytoMed Therapeutics Investor Relations Material
Latest events

H1 2024
CytoMed Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CytoMed Therapeutics Limited
Access all reports
CytoMed Therapeutics Limited is a biotechnology company focused on developing cell-based immunotherapies for cancer treatment. The company leverages advanced cellular technology to create novel therapeutic solutions that harness the immune system’s capabilities to target and eliminate cancer cells. CytoMed's research and development efforts concentrate on proprietary cell therapy platforms that aim to offer effective, potentially less toxic alternatives to conventional cancer treatments. CytoMed Therapeutics Limited is headquartered in Singapore, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
GDTC
Country
🇺🇸 United States